Arbutus Biopharma Statistics

Total Valuation

ABUS has a market cap or net worth of $850.07 million. The enterprise value is $760.98 million.

Market Cap	850.07M
Enterprise Value	760.98M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ABUS has 192.32 million shares outstanding. The number of shares has increased by 5.88% in one year.

Current Share Class	192.32M
Shares Outstanding	192.32M
Shares Change (YoY)	+5.88%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	48.87%
Float	126.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.78
Forward PS	555.60
PB Ratio	10.96
P/TBV Ratio	10.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	52.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.80, with a Debt / Equity ratio of 0.06.

Current Ratio	18.80
Quick Ratio	18.31
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-287.66

Financial Efficiency

Return on equity (ROE) is -45.88% and return on invested capital (ROIC) is -20.03%.

Return on Equity (ROE)	-45.88%
Return on Assets (ROA)	-16.46%
Return on Invested Capital (ROIC)	-20.03%
Return on Capital Employed (ROCE)	-33.89%
Revenue Per Employee	$331,955
Profits Per Employee	-$960,841
Employee Count	44
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.18% in the last 52 weeks. The beta is 0.66, so ABUS's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+18.18%
50-Day Moving Average	4.44
200-Day Moving Average	3.70
Relative Strength Index (RSI)	50.60
Average Volume (20 Days)	1,096,334

Short Selling Information

The latest short interest is 10.56 million, so 5.49% of the outstanding shares have been sold short.

Short Interest	10.56M
Short Previous Month	9.92M
Short % of Shares Out	5.49%
Short % of Float	8.38%
Short Ratio (days to cover)	10.81

Income Statement

In the last 12 months, ABUS had revenue of $14.61 million and -$42.28 million in losses. Loss per share was -$0.22.

Revenue	14.61M
Gross Profit	-14.44M
Operating Income	-31.36M
Pretax Income	-42.28M
Net Income	-42.28M
EBITDA	-30.67M
EBIT	-31.36M
Loss Per Share	-$0.22

Full Income Statement

Balance Sheet

The company has $93.70 million in cash and $4.61 million in debt, giving a net cash position of $89.10 million or $0.46 per share.

Cash & Cash Equivalents	93.70M
Total Debt	4.61M
Net Cash	89.10M
Net Cash Per Share	$0.46
Equity (Book Value)	77.40M
Book Value Per Share	0.40
Working Capital	92.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.27 million and capital expenditures -$86,000, giving a free cash flow of -$45.36 million.

Operating Cash Flow	-45.27M
Capital Expenditures	-86,000
Free Cash Flow	-45.36M
FCF Per Share	-$0.24

Full Cash Flow Statement

Margins

Gross margin is -98.86%, with operating and profit margins of -214.67% and -289.45%.

Gross Margin	-98.86%
Operating Margin	-214.67%
Pretax Margin	-289.45%
Profit Margin	-289.45%
EBITDA Margin	-209.98%
EBIT Margin	-214.67%
FCF Margin	n/a

Dividends & Yields

ABUS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.88%
Shareholder Yield	-5.88%
Earnings Yield	-4.97%
FCF Yield	-5.34%

Analyst Forecast

The average price target for ABUS is $5.00, which is 13.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	13.12%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABUS has an Altman Z-Score of 0.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.23
Piotroski F-Score	4